GMP and research-grade vector production facilities.

Manufacturing Biotherapeutics to GMP standard for clinical trials can be one of the most difficult hurdles to overcome.

Below are a number of facilities capable of manufacturing clinical and pre-clinical grade therapeutics including plasmid, oligonucleotides and viral vectors. There are also a selection of facilities capable of conducting the range of tests necessary to meet safety standards.

Aldevron Almac Amsterdam Molecular Technologies
Angel Bio Avecia Biologics Avigen
Bio Products Laboratory Biogenova Bioprocessing Technology Institute
Bioreliance Ltd Biotec Distribution Wales Limited Boehringer Ingelheim RCV
Cancer Research UK CellGenix Celltec
Clinical Biomanufacturing Facility, Oxford Cobra Biomanufacturing Covance
Eden Biodesign Ltd Emergent Product Development UK Limited EUFETS AG
Eurogentec s.a. Gene Therpy Centre, Huddinge Hospital, Karolinska Institutet GeneArt/Genovac
Genethon Genethon Genzyme Limited
Henogen Henogen Introgen
Invitrogen/Bioreliance Lentigen Lonza Biologics
Microsafe BV Molmed NHSBT, Clinical Biotechnology Centre
Npil Pharmaceuticals (UK) Limited Omnia Biologics, Inc. PacificGMP
Plasmid Factory Polyplus-Transfection Powell Gene Therapy Centre, University of Florida
Protherics UK Limited Qbiogene Qiagen
Quintiles Limited Rentschler Biotechnologie Targeted Genetics
Texcell, a Pasteur Institute Co The Goldyne Saved Institute of Gene and therapy, Jerusalem, Israel Ucb Celltech
Vector Biolabs Vecura VirXsys